Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
248 participants
OBSERVATIONAL
2018-10-16
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DEXA Bone Density Analysis of the CoreHip® Prosthesis System
NCT06632301
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NCT04943328
A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement Surgery
NCT01383824
Cup Position in THA With Standard Instruments
NCT03189303
Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
NCT02162186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CoreHip
Clinical and Radiological Data of 300 patients of a Standard Patient Population, who are treated with CoreHip Total Hip Arthroplasty for Indications according to the Instructions for Use (IfU) with a five year follow Up
CoreHip Total Hip Arthroplasty
Replacement of the Hip Joint
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CoreHip Total Hip Arthroplasty
Replacement of the Hip Joint
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for THA with a CoreHip® stem
* Written informed consent
Exclusion Criteria
* Patient age \< 18 years
* Patient not able to regularly participate at the follow-up examinations
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henning Windhagen, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Orthopädische Kliniken im Annastift, Medizinische Hochschule Hannover
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ortrhopädische Klinik Markgröningen
Markgröningen, Baden-Wurttemberg, Germany
Orthopädische Chirurgie München
München, Bavaria, Germany
MHH
Hanover, Lower Saxony, Germany
St. Josefs Krankenhaus Endoprothetik Zentrum
Salzkotten, , Germany
Spital Brig
Brig, , Switzerland
Luzerner Kantonsspital Sursee
Sursee, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-1509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.